Skip to content
Reviewed against editorial standards · Updated 2026-01-29

Thymosin Beta-4: Dosage & Administration

Part of the Thymosin Beta-4 Complete Guide

Partner

Research Peptides

BioLongevity Labs15% Off
Shop Peptides at BioLongevity Labs

Advertiser link — we may earn a commission at no extra cost to you.

Thymosin Beta-4 Dosage Protocols

Thymosin beta-4 (Tβ4) dosing in research typically follows a loading and maintenance approach, similar to its fragment TB-500:

PhaseDoseFrequencyDuration
Loading750 mcg – 2 mgOnce or twice daily2–4 weeks
Maintenance750 mcg – 2 mg2–3× weekly4–8 weeks

Thymosin beta-4 is the full-length 43-amino-acid peptide, while TB-500 is a synthetic fragment containing the active region. The full-length molecule has been more extensively studied in formal clinical trials, while TB-500 is more common in research settings due to cost and availability.

Reconstitution & Preparation

Thymosin beta-4 comes in lyophilized form:

  • Reconstitute with bacteriostatic water following standard procedures
  • Inject subcutaneously — abdomen or thigh
  • The peptide acts systemically — injection location does not need to be near the injury site

Use the peptide calculator for volumes. See the reconstitution guide for preparation.

Timing & Cycle Length

Thymosin beta-4 timing:

  • Time of day: No strict requirement. Any time of day is acceptable
  • Total cycle: Loading (2–4 weeks) + maintenance (4–8 weeks) = 6–12 weeks total
  • Injury-related use: Begin as soon as possible after injury for maximum benefit
  • No fasting required

Storage

Standard peptide storage:

  • Lyophilized: -20°C long-term, 2–8°C for months
  • Reconstituted: Refrigerate at 2–8°C, use within 28 days

See the peptide storage guide.

FAQ

Frequently Asked Questions

References

  1. [1] Goldstein AL, et al.. Thymosin beta 4: a multi-functional regenerative peptide. Expert Opinion on Biological Therapy, 2012.
  2. [2] Crockford D, et al.. Thymosin beta 4: structure, function, and biological properties supporting current and future clinical applications. Annals of the New York Academy of Sciences, 2010.

Researching peptides? We did the hard part.

Get our free Peptide Starter Kit — the 5 most researched compounds, simplified into one actionable guide.

No spam · Unsubscribe anytime

Related Reading

AD
Austin Danner

Founder & Editor in Chief

Founder of Peptides Insider. Independent researcher focused on translating peer-reviewed peptide research into practical, evidence-based guides.

Reviewed against Peptides Insider editorial standards · Last reviewed 2026-01-29.